158
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma: Kim HL, Seligson D, Liu X, Janzen N, Bui MHT, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA, Department of Urologic Oncology, Roswell Park Cancer Institute, B
960
Utility of Gains and Losses: Measurement–Theoretical and Experimental Approaches: R. Duncan Luce, Lawrence Erlbaum Associates, Mahwah, NJ, USA, 1999, 331 pp., Author Index, Subject Index, US$ 59.95, ISBN 0-8058-3460-5